Navigation Links
Obese people are more sensitive to pain, suggests study

according to Emery, a small number of studies have looked at pain sensitivity in obese people, but many of these studies report conflicting results.

"Some studies say that obese people are more tolerant of pain, while other studies say they are less tolerant," Emery said.

About a third of the study's 62 participants were obese. Researchers determined who was obese based on participants' body mass index (BMI) scores, which relates height to weight. Obese patients in this study had a BMI greater than 30 but less than 35. (Scores higher than 35 are considered morbidly obese.)

The participants underwent two rounds of electrical stimulation ?once before, and once after a 45-minute training session where they learned different ways of coping with pain, including instruction in progressive muscle relaxation therapy.

The electrical stimulation came from an iPod-sized device that delivered a slight electrical shock to a patient's sural nerve, a nerve that extends along the ankle and into the calf. This kind of electrical stimulation causes sensations of tingling and mild pain in the lower leg.

The researchers determined the body's response to sural nerve stimulation by measuring the reflex of the lower leg muscles that surround the sural nerve. When the brain senses pain, it sends a message to the body to contract and move the muscles in order to get away from the source of the pain.

"This kind of evaluation is in some ways a more objective way of measuring the body's response to pain, as opposed to simply asking someone if they feel pain," Emery said.

But the researchers did ask participants how much pain they felt. Participants completed questionnaires about anxiety and pain perception after each round of electrical stimulations. All participants, obese or not, reported that they felt less pain after the relaxation session than they did before.

Yet results of the sural nerve stimulus test showed that the obes
'"/>

Source:Ohio State University


Page: 1 2 3

Related biology news :

1. New insight into people who see colors in letters and numbers
2. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
3. Increased risk of osteoporosis associated with gene that one in five people have
4. Exercise training in ordinary people affects the activity of 500 genes
5. Brain activity related to processing faces is similar in people with, without autism
6. Newly identified mechanism helps explain why people of African descent are more vulnerable to TB
7. Less antibiotic use in food animals leads to less drug resistance in people, study shows
8. Nearly half of people who need cholesterol treatment dont get it
9. Slow-frozen people? Latest research supports possibility of cyropreservation
10. Some people would give life or limb not to be fat
11. Carnegie Mellon researchers discover key deficiencies in brains of people with autism

Post Your Comments:
(Date:12/1/2009)... December 1, 2009: OptiNose is pleased to announce...ical study investigating the efficacy and tolerabi...for the topical treatment of chronic rhinosinusiti...ournal of the International and European Rhinologi...l polyps is a chronic disease that can significant...
(Date:12/1/2009)... This release is available in German . , Bro.... It contains loads of mitochondria, miniature po...at. In doing this, they normally generate a voltag...s energy for cellular processes. However, the mito...They go full steam ahead all the time. The energy ...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Wound Management Technologies Acquires Resorbable Orthopedics 5146 1Wound Management Technologies Acquires Resorbable Orthopedics 5146 2Wound Management Technologies Acquires Resorbable Orthopedics 5146 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 1Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 2Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 4
...ent has awarded five faculty planning grants to de... help solve the world,s urgent demands for fresh w... and well-being, yet in poor countries more than a...ies, and more than 2 billion lack basic sanitation...ichard Luthy, a professor of civil and environment...
...ther nature or nurture determines an ant,s status ...oth. , Nature (that is, the ant,s genetic makeup)...le in determining the fate of the Florida harveste...ound in many parts of the southeastern United Stat...the University of Illinois, the University of Ariz...
...dical Center immunologist and blood and marrow tra...e as the study co-chair for a new national clinica...rd blood transplants for severe sickle cell dise...ther medical institutions in the first-ever Phase ..., the Sickle Cell Unrelated Transplant (SCURT) tri...
Other Biology News:New planning grants to fund research on freshwater issues 2New planning grants to fund research on freshwater issues 3Genes and nutrition influence caste in unusual species of harvester ant 2Genes and nutrition influence caste in unusual species of harvester ant 3Children's national co-leads nationwide study of landmark sickle cell treatment 2
(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswi... is proud to announce that it was recently awarded...Awards event on Nov. 13 in New York City. The CLIO...and innovation in the healthcare advertising indus... the world,s most recognized awards competitions f...
(Date:12/1/2009)... Congruent Software agree...including project accounting clients) to Synergy B... Seattle, WA (PRWEB) Decemb... today it has acquired the Microsoft Dynamics SL p...ness technology provider. The move was necessary d...
(Date:12/1/2009)..., , INDIANAPOLIS and NORTH VANCOUVER, Bri...w AgroSciences LLC, a wholly owned subsidiary of T...ma Biosciences, Inc. today announced the signing o...nt. The agreement provides Dow AgroSciences with a...oci (ETL) technology on an exclusive basis in majo...
(Date:12/1/2009)..., , ATLANTA, Dec. 1 /PRNewswire-FirstCal...X) (the "Company"), an Atlanta-based, biopharmaceu...es caused by HIV-1 (Human Immunodeficiency Virus) ...upport for World AIDS Day. ,, "Today is the 21s...hat have lost their fight with the HIV/AIDS pandem...
Breaking Biology Technology:Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
...Revenues Up 61%, Six-Month Net Revenues Up 40%, ET...arter and 67% for Six ...% for Second Quarter and 14% for Six ... Pharmaceutical Company,(NYSE: KVa/KVb) today repo...ng revenue and earnings growth for the second quar...
...Nov. 19 Beckman Coulter,Inc. (NYSE: BEC ), a lea...ucts that simplify, automate, and innovate complex...ynor, Beckman Coulter,s director of investor,relat...y Healthcare,Conference on Wednesday, November 28,...com.com/cgi-bin/prnh/20031202/BECLOGO ) The live ...
.... 19 Advanced Instruments, Inc., of,Norwood, Mass...0% of the,shares of Mart Microbiology B.V. of The ... disclosed. Mart Microbiology manufactures and ma...systems create custom environments for anaerobic,b...en-deprived atmospheres.,Typical applications incl...
Other Biology Technology:KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 2KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 3KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 4KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 5KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 6KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 7KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 8KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 9KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 10Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference 2Advanced Instruments Acquires Mart Microbiology B.V. 2
Anti-Human Apolipoprotein B100 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Anti-Mouse Ameloblastin Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Goat Anti-Human SOST Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human CDC23 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: